Early high-dose continuous veno-venous hemofiltration alleviates the alterations of CD4+ T lymphocyte subsets in septic patients combined with acute kidney injury.
Jin B, Cao D, Yang N, Wang L, Li R, Liu X, Gong P.
Artif Organs. 2022 Jul;46(7):1415-1424. doi: 10.1111/aor.14199. Epub 2022 Feb 17.
PMID:35132659
Continuous renal replacement therapy and extended indications.
Ronco C, Reis T.
Semin Dial. 2021 Nov;34(6):550-560. doi: 10.1111/sdi.12963. Epub 2021 Mar 12.
PMID:33711166
Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation.
Margraf A, Liu C, Küllmar M, Meersch M, Rossaint J, Zarbock A.
Cells. 2022 Jun 1;11(11):1815. doi: 10.3390/cells11111815.
PMID:35681510
Prognostic risk factors in patients with refractory heart failure treated with continuous veno-venous hemofiltration.